Development and Validation of a Predictive Model for Intracranial Haemorrhage in Patients on Direct Oral Anticoagulants — Yuanyuan Liu (2024) | RDL Network
Development and Validation of a Predictive Model for Intracranial Haemorrhage in Patients on Direct Oral Anticoagulants
Article 2024 en
Authors
YL
Yuanyuan Liu
LL
Linjie Li
JL
Jingge Li
Abstract
1 min read
In a real-world Chinese population using DOAC therapy, this study presents a reliable predictive model for ICH risk. The XGBoost model, integrating six key risk factors, offers a valuable tool for individualized risk assessment in the context of oral anticoagulation therapy.
David Seiffge, Maurizio Paciaroni, Duncan Wilson, Masatoshi Koga, Kosmas Macha, Manuel Cappellari, Sabine Schaedelin, Clare Shakeshaft, Masahito Takagi, Georgios Tsivgoulis, Bruno Bonetti, Bernd Kallmünzer, Shoji Arihiro, Andrea Alberti, Alexandros A. Polymeris, Gareth Ambler, Sohei Yoshimura, Michele Venti, Leo H. Bonati, Keith W. Muir, Hiroshi Yamagami, Sebastian Thilemann, Riccardo Altavilla, Nils Peters, Manabu Inoue, Tobias Bobinger, Giancarlo Agnelli, Martin M. Brown, Shoichiro Sato, Monica Acciarresi, Hans Rolf Jäger, Paolo Bovi, Stefan Schwab, Philippe Lyrer, Valeria Caso, Ḱazunori Toyoda, David J. Werring, Stefan T. Engelter, Gian Marco De Marchis
María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Martín Ruiz Ortiz, Javier Muñiz, Inmaculada Roldán‐Rabadán, Déborah Otero, Raquel López‐Gálvez, Ángel Cequier, Vicente Bertoméu, Lina Badimón, Manuel Anguita, Professor Gregory Lip, Francisco Marı́n
Discussion(0)
No comments yet. Be the first to comment.